Latest Announcements

BSE & NSE corporate filings with AI summaries

NSEInvestor Presentation▲ PositiveResults5 Aug 2026

Navin Fluorine International Limited

Investor Presentation

Navin Fluorine International Limited has informed the Exchange about Investor Presentation for Q1 of Financial Year 2026-27, with business highlights including 44% YoY revenue growth, 11% QoQ growth, and 73% YoY growth in HPP segment.

Read more →📎 1 attachment
NSEBagging/Receiving of orders/contracts▲ PositiveOrder Win5 Aug 2026

Medico Remedies Limited

Bagging/Receiving of orders/contracts

Medico Remedies Limited has secured a government supply order worth USD 1.40645 million from PROMESE/CAL, Dominican Republic, to supply tablets, capsules, and dry syrups. The order is expected to be completed within 3 months.

Read more →📎 1 attachment
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults5 Aug 2026

National Aluminium Company Limited

Analysts/Institutional Investor Meet/Con. Call Updates

National Aluminium Company Limited has announced its Q1 FY27 earnings, with a 39% growth in total income and 88% growth in PBT, driven by a substantial increase in revenue collection and profitability. The company has achieved its targets in production and has recorded its best ever quarter in bauxite, hydrate production, and wind power generation.

Read more →📎 1 attachment
BSEResult▲ PositiveResults5 Aug 2026

Navin Fluorine International Ltd-$

Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2026

Navin Fluorine International Ltd has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The company has reported a total revenue of ₹1,045.08 crore, with expenses of ₹442.42 crore. The net profit for the quarter is ₹318.36 crore. The company has also approved a capital expenditure of ₹90 crores for establishing adoption capacities to progress products forming part of its Advanced Materials portfolio.

Read more →📎 1 attachment
NSEInvestor Presentation▲ PositiveResults5 Aug 2026

Neuland Laboratories Limited

Investor Presentation

Neuland Laboratories Limited has presented its Q1FY27 financial results, showing a 116.3% YoY increase in total income to Rs. 650.1 crore, with EBITDA margin increasing by 2150 bps YoY to 35.5%. The company's net debt stood at Rs. (308.5) crore as at Q1FY27 end.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults5 Aug 2026

Neuland Laboratories Ltd

Investor Presentation on the Financial Results of the Company for the quarter ended June 30, 2026

Neuland Laboratories Ltd has announced its Q1FY27 financial results, with total income at Rs. 650.1 crore, EBITDA at Rs. 231.1 crore, and PAT at Rs. 147.4 crore, showing significant year-over-year growth. The company's working capital days of sale decreased to 84 days in Q1FY27 from 137 days in Q4FY26, and capex outflow was Rs. 122 Cr in Q1FY27.

Read more →📎 1 attachment
BSECompany Update▲ PositiveOrder Win5 Aug 2026

Medico Remedies Ltd

Please find enclosed

Medico Remedies Ltd has secured a government supply order worth USD 1.4 million from PROMESE/CAL, Dominican Republic, to supply tablets, capsules, and dry syrups within 3 months.

Read more →📎 1 attachment
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults5 Aug 2026

Kalpataru Limited

Analysts/Institutional Investor Meet/Con. Call Updates

Kalpataru Limited has informed the Exchange about the Transcript of Earnings conference call on Unaudited Standalone and Consolidated Financial Results for the first quarter ended June 30, 2026. The company delivered a steady start to the fiscal year, driven by operational momentum, robust sales collections, strategic projects launches, and continued execution across core micro-markets.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults5 Aug 2026

Kalpataru Ltd

Transcript of Earnings Conference Call

Kalpataru Ltd's Q1 FY27 earnings conference call transcript has been released, with the company delivering a steady start to the fiscal year driven by operational momentum, robust sales collections, and strategic project launches.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults5 Aug 2026

Cantabil Retail India Ltd

Investor Presentation

Cantabil Retail India Ltd has released an investor presentation for the quarter ended June 30, 2026, highlighting key operational updates, performance highlights, and financial metrics. The company added 15 stores in Q1 FY27, increasing total retail area to 9.42 lakh sq. ft. Revenue and profitability have shown growth, with a 13% increase in revenue and 21% growth in profit before tax (PBT).

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults5 Aug 2026

Garware Technical Fibres Limited

Press Release

Garware Technical Fibres Ltd. has announced its unaudited financial results for Q1FY27, with a 31.4% increase in net sales to Rs. 482.4 Cr and a 22.7% increase in profit before tax to Rs. 86.4 Cr.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults5 Aug 2026

Cantabil Retail India Limited

Press Release

Cantabil Retail India Limited has announced its Q1 FY27 financial results, reporting a 13% revenue growth and 21% EBIDTA growth, with an industry-leading EBIDTA margin of 33.2%. The company has also maintained a strong same-store sales growth of 4.04% and has reported a PAT growth of 11%.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults5 Aug 2026

Cantabil Retail India Ltd

Press Release

Cantabil Retail India Ltd reported Q1 FY27 results with revenue growth of 13% and EBIDTA growth of 21%, with industry-leading EBIDTA margin of 33.2%. The company maintained a strong balance sheet and delivered a robust SSG of 4.04%. The management expressed confidence in achieving new milestones in FY2027 and creating lasting value for stakeholders.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults5 Aug 2026

Neuland Laboratories Limited

Press Release

Neuland Laboratories Limited has announced its Q1FY27 financial results, with total income at Rs.650.1 crore and EBITDA at Rs.231.1 crore, representing a 116.3% and 448.2% YoY increase respectively.

Read more →📎 1 attachment
NSEOutcome of Board Meeting▲ PositiveResults5 Aug 2026

N R Agarwal Industries Limited

Outcome of Board Meeting

N R Agarwal Industries Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, with a net profit of ₹349.75 crore and a total comprehensive income of ₹350.89 crore.

Read more →📎 1 attachment
← PreviousPage 739 of 994Next →